UPDATE: Sterne Agee Upgrades Cardinal Health to Buy, Raises PT on New Valuation


27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


In a report published Wednesday, Sterne Agee analyst Greg T. Bolan upgraded the rating on

27% profits every 20 days?

This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Cardinal Health (NYSE: CAH) from Neutral to Buy, and raised the price target from $59.00 to $73.00.In the report, Sterne Agee noted, “After much thought and analysis, we feel it appropriate to raise our estimates and price target for CAH. Based on our new valuation, we believe investors should actively accumulate CAH shares. We believe superior EPS growth to that of S&P 500 operating EPS warrants a superior valuation multiple to the S&P, and as such, believe investors will outperform the broader markets by owning CAH shares.”Cardinal Health closed on Tuesday at $60.56.
Posted In: Analyst ColorUpgradesAnalyst RatingsGreg T. BolanSterne Agee